Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer

Lung Cancer

Volumn 55, Issue 3, 2007, Pages 303-311

  Liu, Chunyan ^a   Zhou, Shaoyu ^a   Begum, Shahnaz ^a   Sidransky, David ^a   Westra, William H ^a   Brock, Malcolm ^a   Califano, Joseph A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Camptothecin resistance; Double strand break repair; MUS81; Non small cell lung cancer; Overexpression of repair genes; Oxidative damage; Single strand break repair; TDP1; Topoisomerase I mediated DNA damage; XPF

Indexed keywords

GENE PRODUCT; PROTEIN MUS81; PROTEIN TDP1; PROTEIN XPF; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RESISTANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA REPAIR; ENZYMATIC ASSAY; EVALUATION; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MALE; PRIORITY JOURNAL; WESTERN BLOTTING;

CAMPTOTHECIN; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ENDONUCLEASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PHOSPHORIC DIESTER HYDROLASES;

EID: 33847326382     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.10.019     Document Type: Article

References (36)

1. Mozzetti S., Ferlini C., Concolino P., Filippetti F., Raspaglio G., Prislei S., et al. Class iii beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin Cancer Res 11 (2005) 298-305
2. Michalides R., Griekspoor A., Balkenende A., Verwoerd D., Janssen L., Jalink K., et al. Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after pka activation in breast cancer. Cancer Cell 5 (2004) 597-605
3. Lord R.V., Brabender J., Gandara D., Alberola V., Camps C., Domine M., et al. Low ercc1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Clin Cancer Res 8 (2002) 2286-2291
4. Pizzolato J.F., and Saltz L.B. The camptothecins. Lancet 361 (2003) 2235-2242
5. Stewart D.J. Update on the role of topotecan in the treatment of non-small cell lung cancer. Oncologist 9 Suppl. 6 (2004) 43-52
6. Nivens M.C., Felder T., Galloway A.H., Pena M.M., Pouliot J.J., and Spencer H.T. Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-i and thymidylate synthase. Cancer Chemother Pharmacol 53 (2004) 107-115
7. Interthal H., Chen H.J., Kehl-Fie T.E., Zotzmann J., Leppard J.B., and Champoux J.J. Scan1 mutant tdp1 accumulates the enzyme-DNA intermediate and causes camptothecin hypersensitivity. EMBO J 24 (2005) 2224-2233
8. Barthelmes H.U., Habermeyer M., Christensen M.O., Mielke C., Interthal H., Pouliot J.J., et al. Tdp1 overexpression in human cells counteracts DNA damage mediated by topoisomerases i and ii. J Biol Chem 279 (2004) 55618-55625
9. Interthal H., Pouliot J.J., and Champoux J.J. The tyrosyl-DNA phosphodiesterase tdp1 is a member of the phospholipase d superfamily. Proc Natl Acad Sci USA 98 (2001) 12009-12014
10. Pouliot J.J., Yao K.C., Robertson C.A., and Nash H.A. Yeast gene for a tyr-DNA phosphodiesterase that repairs topoisomerase i complexes. Science 286 (1999) 552-555
11. Raymond A.C., and Burgin Jr. A.B. Tyrosyl-DNA phosphodiesterase (tdp1) (3′-phosphotyrosyl DNA phosphodiesterase). Methods Enzymol 409 (2006) 511-524
12. Interthal H., Chen H.J., and Champoux J.J. Human tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages. J Biol Chem 280 (2005) 36518-36528
13. Davies D.R., Interthal H., Champoux J.J., and Hol W.G. Crystal structure of a transition state mimic for tdp1 assembled from vanadate, DNA, and a topoisomerase i-derived peptide. Chem Biol 10 (2003) 139-147
14. Davies D.R., Interthal H., Champoux J.J., and Hol W.G. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (tdp1) from vanadate and tungstate-inhibited structures. J Mol Biol 324 (2002) 917-932
15. Houtsmuller A.B., Rademakers S., Nigg A.L., Hoogstraten D., Hoeijmakers J.H., and Vermeulen W. Action of DNA repair endonuclease ercc1/xpf in living cells. Science 284 (1999) 958-961
16. Kaliraman V., Mullen J.R., Fricke W.M., Bastin-Shanower S.A., and Brill S.J. Functional overlap between sgs1-top3 and the mms4-mus81 endonuclease. Genes Dev 15 (2001) 2730-2740
17. Chen X.B., Melchionna R., Denis C.M., Gaillard P.H., Blasina A., Van de Weyer I., et al. Human mus81-associated endonuclease cleaves holliday junctions in vitro. Mol Cell 8 (2001) 1117-1127
18. Liu C., Pouliot J.J., and Nash H.A. Repair of topoisomerase i covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase tdp1. Proc Natl Acad Sci USA 99 (2002) 14970-14975
19. Yang S.W., Burgin Jr. A.B., Huizenga B.N., Robertson C.A., Yao K.C., and Nash H.A. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type i topoisomerases. Proc Natl Acad Sci USA 93 (1996) 11534-11539
20. Pouliot J.J., Robertson C.A., and Nash H.A. Pathways for repair of topoisomerase i covalent complexes in Saccharomyces cerevisiae. Genes Cells 6 (2001) 677-687
21. Xu Z.Y., Loignon M., Han F.Y., Panasci L., and Aloyz R. Xrcc3 induces cisplatin resistance by stimulation of rad51-related recombinational repair, s-phase checkpoint activation, and reduced apoptosis. J Pharmacol Exp Ther 314 (2005) 495-505
22. Furuchi T., Nitta K., Takahashi T., and Naganuma A. Overexpression of ssl2p confers resistance to adriamycin and actinomycin d in Saccharomyces cerevisiae. Biochem Biophys Res Commun 314 (2004) 844-848
23. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat Med 10 (2004) 789-799
24. Inamdar K.V., Pouliot J.J., Zhou T., Lees-Miller S.P., Rasouli-Nia A., and Povirk L.F. Conversion of phosphoglycolate to phosphate termini on 3′ overhangs of DNA double strand breaks by the human tyrosyl-DNA phosphodiesterase htdp1. J Biol Chem 277 (2002) 27162-27168
25. Strumberg D., Pilon A.A., Smith M., Hickey R., Malkas L., and Pommier Y. Conversion of topoisomerase i cleavage complexes on the leading strand of ribosomal DNA into 5′-phosphorylated DNA double-strand breaks by replication runoff. Mol Cell Biol 20 (2000) 3977-3987
26. Tsao Y.P., Russo A., Nyamuswa G., Silber R., and Liu L.F. Interaction between replication forks and topoisomerase i-DNA cleavable complexes: Studies in a cell-free sv40 DNA replication system. Cancer Res 53 (1993) 5908-5914
27. Vance J.R., and Wilson T.E. Yeast tdp1 and rad1-rad10 function as redundant pathways for repairing top1 replicative damage. Proc Natl Acad Sci USA 99 (2002) 13669-13674
28. El-Khamisy S.F., and Caldecott K.W. Tdp1-dependent DNA single-strand break repair and neurodegeneration. Mutagenesis 21 (2006) 219-224
29. Takashima H., Boerkoel C.F., John J., Saifi G.M., Salih M.A., Armstrong D., et al. Mutation of tdp1, encoding a topoisomerase i-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat Genet 32 (2002) 267-272
30. El-Khamisy S.F., Saifi G.M., Weinfeld M., Johansson F., Helleday T., Lupski J.R., et al. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 434 (2005) 108-113
31. Plo I., Liao Z.Y., Barcelo J.M., Kohlhagen G., Caldecott K.W., Weinfeld M., et al. Association of xrcc1 and tyrosyl DNA phosphodiesterase (tdp1) for the repair of topoisomerase i-mediated DNA lesions. DNA Repair (Amst) 2 (2003) 1087-1100
32. Paz-Elizur T., Krupsky M., Blumenstein S., Elinger D., Schechtman E., and Livneh Z. DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst 95 (2003) 1312-1319
33. Popanda O., Schattenberg T., Phong C.T., Butkiewicz D., Risch A., Edler L., et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25 (2004) 2433-2441
34. Zhou T., Lee J.W., Tatavarthi H., Lupski J.R., Valerie K., and Povirk L.F. Deficiency in 3′-phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (tdp1). Nucleic Acids Res 33 (2005) 289-297
35. Nitiss K.C., Malik M., He X., White S.W., and Nitiss J.L. Tyrosyl-DNA phosphodiesterase (tdp1) participates in the repair of top2-mediated DNA damage. Proc Natl Acad Sci USA 103 (2006) 8953-8958
36. Liu C., Pouliot J.J., and Nash H.A. The role of tdp1 from budding yeast in the repair of DNA damage. DNA Repair (Amst) 3 (2004) 593-601